Earnings History Data for Checkpoint Therapeutics (CKPT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Checkpoint Therapeutics

Checkpoint Therapeutics, Inc. is a clinical stage, immuno oncology biopharmaceutical. It focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics, Inc. is headquartered in New York City.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
22-03-2024	PM		CKPT	Checkpoint Therapeutics	44.00	-1.10	-0.74	0.00	Checkpoint Therapeutics GAAP EPS of -$3.17 misses by $0.49, revenue of $0.1M misses by $0.02M [3/22/2024 9:05 AM]	1.92	0.02 (1.05%)	1.94	0.04 (2.11%)	1.30 - 4.29	475,010	350,000	2,586
Checkpoint Therapeutics GAAP EPS of -$3.17 misses by $0.49, revenue of $0.1M misses by $0.02M [3/22/2024 9:05 AM]
15-05-2023	AH		CKPT	Checkpoint Therapeutics	36.00	-0.89	-0.92	0.00	Checkpoint Therapeutics GAAP EPS of -$0.89 [5/15/2023 4:58 PM]	2.78	-0.05 (-1.77%)	2.88	0.05 (1.77%)	1.84 - 14.90	298,973	210,000	3,772
Checkpoint Therapeutics GAAP EPS of -$0.89 [5/15/2023 4:58 PM]
08-11-2022	AH	After the close (Nov 8)	CKPT	Checkpoint Therapeutics	84.00	-0.12	-0.17	0.00	Checkpoint Therapeutics GAAP EPS of -$0.12 beats by $0.03, revenue of $0.05M [11/8/2022 5:10 PM]	0.6898	-0.03 (-3.65%)	0.75	0.03 (4.76%)	0.50 - 4.54	559,965	450,000	1,355
Checkpoint Therapeutics GAAP EPS of -$0.12 beats by $0.03, revenue of $0.05M [11/8/2022 5:10 PM] Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights [Nov-08-22 04:30PM]
12-08-2022	PM		CKPT	Checkpoint Therapeutics, Inc.	107.41	-0.16	-0.17	-0.12	Checkpoint Therapeutics GAAP EPS of -$0.16 in-line, revenue of $0.02M beats by $0.01M [8/12/2022 8:25 AM]	1.29	0.03 (2.38%)	1.23	-0.03 (-2.38%)	0.96 - 4.64	260,107	470,000	18,599
Checkpoint Therapeutics GAAP EPS of -$0.16 in-line, revenue of $0.02M beats by $0.01M [8/12/2022 8:25 AM] Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights [Aug-12-22 08:00AM]
28-03-2022	PM	Before the open (Mar 28)	CKPT	Checkpoint Therapeutics	158.00	-0.39	-0.14	0.00	Checkpoint Therapeutics GAAP EPS of -$0.75 misses by $0.24, revenue of $0.27M misses by $0.09M [3/28/2022 8:03 AM]	1.72	-0.06 (-3.37%)	1.73	-0.05 (-2.80%)	1.49 - 4.64	792,437	700,000	3,751
Checkpoint Therapeutics GAAP EPS of -$0.75 misses by $0.24, revenue of $0.27M misses by $0.09M [3/28/2022 8:03 AM] Checkpoint Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Highlights [Mar-28-22 07:30AM]
04-11-2021	AH	4:30 PM ET (Nov 4)	CKPT	Checkpoint Therapeutics, Inc.	312.76	-0.14	-0.13	-0.09	Checkpoint Therapeutics EPS in-line, misses on revenue [11/4/2021 5:30 PM]	4.24	0.04 (0.83%)	4.00	-0.21 (-4.99%)	2.20 - 5.38	975,673	1,050,000	16,405
Checkpoint Therapeutics EPS in-line, misses on revenue [11/4/2021 5:30 PM] A Look At The Intrinsic Value Of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) [Nov-04-21 07:50AM] Checkpoint Therapeutics Reports Third Quarter 2021 Financial Results [Nov-04-21 04:30PM]
05-08-2021	AH		CKPT	Checkpoint Therapeutics, Inc.	213.00	-0.12	-0.09	-0.09	Checkpoint Therapeutics EPS misses by $0.02, beats on revenue [8/5/2021 5:26 PM]	2.60	0.05 (1.96%)	2.57	0.02 (0.78%)	1.90 - 5.38	572,748	660,000	20,233
Checkpoint Therapeutics Reports Second Quarter 2021 Financial Results [Aug-05-21 04:30PM] Checkpoint Therapeutics (NASDAQ:CKPT) Is In A Good Position To Deliver On Growth Plans [Aug-06-21 02:13AM]
06-05-2021	AH		CKPT	Checkpoint Therapeutics, Inc.	218.12	-0.09	-0.13	-0.06	Checkpoint Therapeutics EPS beats by $0.01, misses on revenue [5/6/2021 5:24 PM]	2.52	0.16 (6.78%)	2.48	0.12 (5.08%)	1.56 - 5.38	1,770,923	930,000	6,957
Checkpoint Therapeutics EPS beats by $0.01, misses on revenue [5/6/2021 5:24 PM] Checkpoint Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Highlights [May-06-21 04:15PM]
09-03-2021	AH		CKPT	Checkpoint Therapeutics, Inc.	225.00	-0.17	-0.08	0.00	Checkpoint Therapeutics EPS misses by $0.09, misses on revenue [3/9/2021 4:37 PM]	3.22	0.03 (0.94%)	3.22	0.03 (0.94%)	1.05 - 5.38	4,553,483	1,398,785	2,748
Checkpoint Therapeutics EPS misses by $0.09, misses on revenue [3/9/2021 4:37 PM] Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights [Mar-09-21 04:30PM] Did You Miss Checkpoint Therapeutics' (NASDAQ:CKPT) 84% Share Price Gain? [Mar-09-21 01:19AM]
04-11-2020	PM		CKPT	Checkpoint Therapeutics, Inc.	136.00	-0.09	-0.08	0.00		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0

04-11-2020	AH		CKPT	Checkpoint Therapeutics, Inc.	161.36	-0.09	-0.08	-0.15	Checkpoint Therapeutics EPS misses by $0.01, misses on revenue [11/4/2020 4:42 PM]	2.44	0.10 (4.49%)	2.30	-0.04 (-1.71%)	1.05 - 4.50	188,089	323,366	660